Open Access
Issue
Med Sci (Paris)
Volume 36, Number 12, Décembre 2020
Vieillissement et mort : de la cellule à l’individu
Page(s) 1199 - 1206
Section La vieillesse et la mort, problématiques comportementales et sociétales
DOI https://doi.org/10.1051/medsci/2020228
Published online 09 December 2020
  1. http://www.mortality.org/. [Google Scholar]
  2. Jones OR, Scheuerlein A, Salguero-Gómez R, et al. Diversity of ageing across the tree of life. Nature 2014 ; 505 : 169–173. [CrossRef] [PubMed] [Google Scholar]
  3. Graunt J. Natural and political observations made upon the bills of mortality. Hull (1864–1936) CH, ed. Cambridge : Cambridge University Press, 1899. [Google Scholar]
  4. Gompertz B. On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies. Phil Trans Roy Soc 1825 : 513–585. [Google Scholar]
  5. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956 ; 11 : 298–300. [CrossRef] [PubMed] [Google Scholar]
  6. Weismann A (1834–1914). Essais sur l’hérédité et la sélection naturelle. Traduction française par Henry de Varigny. 1892. [Google Scholar]
  7. Medawar PB. An unsolved problem of biology. Med J Aust 1952 ; 1 : 854–855. [Google Scholar]
  8. Williams GC. Pleiotropy, natural selection, and the evolution of senescence. Evolution 1957 ; 11 : 398–411. [CrossRef] [Google Scholar]
  9. Kirkwood TB. Evolution of ageing. Nature 1977 ; 270 : 301–304. [CrossRef] [PubMed] [Google Scholar]
  10. Lemoine M. Defining aging. Biology Philosophy 2020; 35 :1–30. [CrossRef] [Google Scholar]
  11. Kenyon C, Chang J, Gensch E, et al. A C. elegans mutant that lives twice as long as wild type. Nature 1993 ; 366 : 461–464. [CrossRef] [PubMed] [Google Scholar]
  12. Clancy DJ, Gems D, Harshman LG, et al. Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 2001 ; 292 : 104–106. [CrossRef] [PubMed] [Google Scholar]
  13. Bluher M, Kahn BB, Kahn CR. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 2003 ; 299 : 572–574. [CrossRef] [PubMed] [Google Scholar]
  14. van Heemst D, Beekman M, Mooijaart SP, et al. Reduced insulin/IGF-1 signalling and human longevity. Aging Cell 2005 ; 4 : 79–85. [CrossRef] [PubMed] [Google Scholar]
  15. Rera M, Clark RI, Walker DW. Intestinal barrier dysfunction links metabolic and inflammatory markers of aging to death in Drosophila. Proc Natl Acad Sci USA 2012 ; 109 : 21528–21533. [CrossRef] [Google Scholar]
  16. Angarita SAK, Duarte S, Russell TA, et al. Quantitative measure of intestinal permeability using blue food coloring. J Surg Res 2019 ; 233 : 20–25. [CrossRef] [PubMed] [Google Scholar]
  17. Dambroise E, Monnier L, Ruisheng L, et al. Two phases of aging separated by the Smurf transition as a public path to death. Sci Rep 2016; 6. [CrossRef] [Google Scholar]
  18. Rera M, Vallot C, Lefrançois C. The Smurf transition: new insights on ageing from end-of-life studies in animal models. Curr Opin Oncol 2018 ; 30 : 38–44. [CrossRef] [PubMed] [Google Scholar]
  19. Horne BD, May HT, Muhlestein JB, et al. Exceptional mortality prediction by risk scores from common laboratory tests. Am J Med 2009 ; 122 : 550–558. [CrossRef] [Google Scholar]
  20. Fischer K, Kettunen J, Würtz P, et al. Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons. PLoS Med 2014 ; 11 : e1001606. [CrossRef] [Google Scholar]
  21. Deelen J, Kettunen J, Fischer K, et al. A metabolic profile of all-cause mortality risk identified in an observational study of 44,168 individuals. Nat Commun 2019 ; 10 : 1–8. [CrossRef] [PubMed] [Google Scholar]
  22. Pinto JM, Wroblewski KE, Kern DW, et al. Olfactory dysfunction predicts 5-year mortality in older adults. PLoS One 2014 ; 9 : e107541. [CrossRef] [Google Scholar]
  23. de Vries NM, Staal JB, Ravensberg CD, et al. Outcome instruments to measure frailty: a systematic review. Ageing Res Rev 2011 ; 10 : 104–114. [CrossRef] [PubMed] [Google Scholar]
  24. Fulop T, Larbi A, Witkowski JM, et al. Aging, frailty and age-related diseases. Biogerontology 2010 ; 11 : 547–563. [CrossRef] [Google Scholar]
  25. Coburn C, Allman E, Mahanti P, et al. Anthranilate fluorescence marks a calcium-propagated necrotic wave that promotes organismal death in C. elegans. PLoS Biol 2013 ; 11 : e1001613. [CrossRef] [PubMed] [Google Scholar]
  26. Yang Y, Santos AL, Xu L, et al. Temporal scaling of aging as an adaptive strategy of Escherichia coli. Sci Adv 2019; 5 : eaaw2069. [CrossRef] [PubMed] [Google Scholar]
  27. Fehrmann S, Paoletti C, Goulev Y, et al. Aging yeast cells undergo a sharp entry into senescence unrelated to the loss of mitochondrial membrane potential. Cell Rep 2013 ; 5 : 1589–1599. [CrossRef] [PubMed] [Google Scholar]
  28. Gaille M, Araneda M, Dubost C, et al. Ethical and social implications of approaching death prediction in humans - when the biology of ageing meets existential issues. BMC Med Ethics 2020; 21 : 64. [CrossRef] [PubMed] [Google Scholar]
  29. Schopenhauer A.. The world as will and representation 1969 ; New York: Dover Publications [Google Scholar]
  30. Lévi-Strauss C. The naked man 1990 ; Chicago: University of Chicago Press 746 p [Google Scholar]
  31. Heidegger M, Stambaugh J, Schmidt DJ. Being and time 2010 ; Albany: State University of New York Press 482 p [Google Scholar]
  32. Epicurus, Inwood B, Gerson LP. The Epicurus reader: selected writings and testimonia. Indianapolis : Hackett, 1994 : 112 p. [Google Scholar]
  33. de Montaigne M.. Les essais 2004 ; Paris: Presses universitaires de France [Google Scholar]
  34. Pascal B, Brunschvicg L, Descotes D, et al. Pensées 2015 ; Paris: Flammarion [Google Scholar]
  35. De M’Uzan M. De, l’art à la mort: itinéraire psychanalytique 1983 ; Paris: Gallimard [Google Scholar]
  36. Raimbault G. L’enfant et la mort: des enfants malades parlent de la mort; problèmes de la clinique du deuil 1977 ; Paris: Privat 222 p [Google Scholar]
  37. Gawande A. Being mortal: medicine and what matters in the end. Macmillan Picador, 2015. [Google Scholar]
  38. Maglio M. Une nouvelle loi pour la fin de vie ?. Détour par l’Italie. Med Sci (Paris) 2019 ; 35 : 258–262. [CrossRef] [Google Scholar]
  39. Gaille M, Horn R. The role of accompagnement in the end-of-life debate in France: from solidarity to autonomy. Theor Med Bioeth 2016 ; 37 : 473–487. [CrossRef] [PubMed] [Google Scholar]
  40. Fouquet C, Brédart A, Bouleuc C. French adaptation of a question prompt list for cancer patients and their carers in supportive and palliative care. Bull Cancer (Paris) 2012; 693–701. [CrossRef] [Google Scholar]
  41. Brandes K, Linn AJ, Butow PN, et al. The characteristics and effectiveness of question prompt list interventions in oncology: a systematic review of the literature: qpl interventions in oncology. Psychooncology 2015 ; 24 : 245–252. [CrossRef] [PubMed] [Google Scholar]
  42. Sébert AL, Schwering KL, Alberti C, et al. Que reste-t-il de l’annonce ? Les enjeux à long terme de l’annonce d’un diagnostic de cancer chez les adolescents et les jeunes adultes : étude qualitative menée auprès de patients traités dans une unité d’hématologie dédiée. Psycho-Oncol 2018 ; 12 : 193–197. [CrossRef] [Google Scholar]
  43. Meyers T. Chroniques de la maladie chronique 2017 ; Paris: PUF 104 p [CrossRef] [Google Scholar]
  44. Wexler A. Mapping fate: a memoir of family, risk, and genetic research 1995 ; Berkeley: University of California Press 321 p [Google Scholar]
  45. Nietzsche F, Wotling P. Le gai savoir 2017 ; Paris: Flammarion [Google Scholar]
  46. Jankélévitch V, Worms F. La mort 2017 ; Paris: Flammarion [Google Scholar]
  47. Houdayer F, Gargiulo M, Frischmann M, et al. The psychological impact of cryptic chromosomal abnormalities diagnosis announcement. Eur J Med Genet 2013 ; 56 : 585–590. [CrossRef] [Google Scholar]
  48. Robins Wahlin TB. To know or not to know: a review of behaviour and suicidal ideation in preclinical Huntington’s disease. Patient Educ Couns 2007 ; 65 : 279–287. [CrossRef] [PubMed] [Google Scholar]
  49. Gargiulo M, Durr A. Anticiper le handicap. Les risques psychologiques des tests génétiques. Esprit 2014; juillet : 52–65. [CrossRef] [Google Scholar]
  50. Novas C, Rose N. Genetic risk and the birth of the somatic individual. Econ Soc 2000 ; 29 : 485–513. [CrossRef] [Google Scholar]
  51. Gao Q, Yuan F, Yang XA, et al. Development and validation of a new score for predicting functional outcome of neurocritically ill patients: the INCNS score. CNS Neurosci Ther 2020; 26 : 21–9. [CrossRef] [Google Scholar]
  52. Kaur J, Mohanti BK. Transition from curative to palliative care in cancer. Indian J Palliat Care 2011 ; 17 : 1–5. [PubMed] [Google Scholar]
  53. Meyricke R, Sherris M. The determinants of mortality heterogeneity and implications for pricing annuities. Insur Math Econ 2013 ; 53 : 379–387. [CrossRef] [Google Scholar]
  54. European Commission. EU rules on gender-neutral pricing in insurance industry enter into force. 2012. https://ec.europa.eu/commission/presscorner/detail/en/IP_12_1430. [Google Scholar]
  55. Villegas AM, Haberman S. On the modeling and forecasting of socioeconomic mortality differentials: an application to deprivation and mortality in England. North Am Actuar J 2014 ; 18 : 168–193. [CrossRef] [Google Scholar]
  56. Foreman KJ, Marquez N, Dolgert A, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet 2018 ; 392 : 2052–2090. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.